Repository logo
 
Publication

Measles antibodies in cord blood in Portugal: Possible consequences for the recommended age of vaccination

dc.contributor.authorGonçalves, Guilherme
dc.contributor.authorNunes, Carla
dc.contributor.authorMesquita, João Rodrigo
dc.contributor.authorNascimento, Maria São José
dc.contributor.authorFrade, João
dc.date.accessioned2025-06-02T16:14:02Z
dc.date.available2025-06-02T16:14:02Z
dc.date.issued2016-05
dc.description.abstractThe optimum age to give the first dose of measles vaccine must balance the risks of disease and vaccinefailure. Both are influenced by the levels of transplacentally acquired maternal antibodies. This study wasconducted in the Obstetric service of Portuguese hospital, in 2012–2013. Mothers were recruited afterinformed consent. Measles IgG was measured in 206 cord sera, using a commercial immunoassay. Geo-metric mean concentrations (and 95% CI) were 1849 mIU/ml (1196–2857) and 790 mIU/ml (618–1008)in cord sera of newborns from unvaccinated and vaccinated mothers respectively. Maternal age and vac-cination status were both associated with the concentration in cord sera, but maternal age was the majorpredictor. The likely explanation is the same already mentioned in other studies: as a vaccination pro-gram progresses, vaccination coverage increases as measles incidence decreases. That results newbornsfrom younger vaccinated mothers having less measles antibodies while the older mothers are more likelyto have been infected with the wild virus. As the proportion of vaccinated mothers increase, developedcountries tend to anticipate the recommended age of the first dose to 12 months of age. Models usinghypothetical measles antibody decay rates in infancy were explored. Anticipating the first dose of MMR1in Portugal to the age of 12 months might have not been the best decision but results were not conclusive,and arguments supporting or not the anticipation were discussed.eng
dc.description.sponsorshipCommercial ELISA Kits were purchase by the Institute ofBiomedical Sciences Abel Salazar (ICBAS), University of Porto, andEscola Superior de Saúde do Instituto Politécnico de Leiria, Portugal.The authors are grateful for the support given by National Schoolof Public Health, Lisbon. Dr. Helder Roque and Dr. Alicia Rita autho-rized the study in the Obstetric Service of the hospital of Leiria,Portugal. Dr. Jorge Costa authorized the consultation of vaccina-tion records in Leiria. Nurses Leonor Silva, Cesaltina Sousa, FátimaSoares, Dina Pascoal, Susana Frade and theirs teams, helped in thecollection of cord blood samples and in the consultation of vac-cination records. The 206 newborns and their mothers are alsogratefully acknowledged.
dc.identifier.citationGuilherme Gonçalves, Carla Nunes, João Rodrigo Mesquita, Maria São José Nascimento, João Frade, Measles antibodies in cord blood in Portugal: Possible consequences for the recommended age of vaccination, Vaccine, Volume 34, Issue 24, 2016, Pages 2750-2757, ISSN 0264-410X, https://doi.org/10.1016/j.vaccine.2016.04.007.
dc.identifier.doi10.1016/j.vaccine.2016.04.007
dc.identifier.issn0264-410X
dc.identifier.urihttp://hdl.handle.net/10400.8/13068
dc.language.isoeng
dc.peerreviewedyes
dc.publisherElsevier BV
dc.relation.hasversionhttps://www.sciencedirect.com/science/article/abs/pii/S0264410X1630127X
dc.relation.ispartofVaccine
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAntibodies
dc.subjectCord blood
dc.subjectMeasles
dc.subjectRecommended age
dc.subjectVaccination
dc.titleMeasles antibodies in cord blood in Portugal: Possible consequences for the recommended age of vaccinationeng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage2757
oaire.citation.issue24
oaire.citation.startPage2750
oaire.citation.titleVaccine
oaire.citation.volume34
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameFrade
person.givenNameJoão
person.identifier.ciencia-idC91E-69C4-8734
person.identifier.orcid0000-0002-4947-1052
relation.isAuthorOfPublicationb73045c9-3871-4883-9dc5-e5693d2861b3
relation.isAuthorOfPublication.latestForDiscoveryb73045c9-3871-4883-9dc5-e5693d2861b3

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1-s2.0-S0264410X1630127X-main.pdf
Size:
840.94 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.32 KB
Format:
Item-specific license agreed upon to submission
Description: